ValiRx plc (LON:VAL – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 0.48 and traded as low as GBX 0.37. ValiRx shares last traded at GBX 0.37, with a volume of 1,338,483 shares traded.
ValiRx Trading Down 3.4%
The firm has a market capitalization of £2.76 million, a price-to-earnings ratio of -0.40 and a beta of 0.59. The company has a quick ratio of 1.27, a current ratio of 6.65 and a debt-to-equity ratio of 0.44. The firm’s 50 day moving average is GBX 0.34 and its 200 day moving average is GBX 0.48.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Articles
- Five stocks we like better than ValiRx
- Wall Street Alert: Buy AES
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- The AI Boom Is Creating a New Kind of Infrastructure Opportunity
- Trump’s Hand-Written Letter Will Shock his Haters
- Bitcoin is down but your income is about to explode
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
